About: Dror Nir
- Website
- Details
- Dror Nir is a visionary entrepreneur committed to identifying and commercializing innovative technologies. In his latest venture Dror recognised the potential of pattern recognition technology founded in air/space imaging industry for medical imaging, he then had the vision, focus and dedication to realise its value in that market. Dror is a leader who values team work and who inspires excellence and commitment from his team.
Posts by Dror Nir:
-
July 11, 2013 Follow-up on Tomosynthesis
-
June 24, 2013 Controlling focused-treatment of Prostate cancer with MRI
-
June 16, 2013 Could Teleradiology contribute to “cross-borders” standardization of imaging protocols in cancer management?
-
June 12, 2013 Imaging of Non-tumorous and Tumorous Human Brain Tissues
-
June 6, 2013 Ultrasound imaging as an instrument for measuring tissue elasticity: “Shear-wave Elastography” VS. “Strain-Imaging”
-
May 21, 2013 Early Detection of Prostate Cancer: American Urological Association (AUA) Guideline
-
May 18, 2013 Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging
-
May 5, 2013 From AUA2013: “Histoscanning”- aided template biopsies for patients with previous negative TRUS biopsies
-
April 28, 2013 Ultrasound-based Screening for Ovarian Cancer
-
April 15, 2013 Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma
Follow Blog via Email
Join 2,038 other subscribers-
Recent Posts
- Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing September 15, 2026
- FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials September 15, 2026
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
Archives
Categories
Meta